Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 5/20 | 0.96 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.56 |
| ▸ | MPO | P05164 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | HTR2A | P28223 | 3/20 | 0.55 |
| ▸ | HTR2C | P28335 | 1/20 | 0.55 |
| ▸ | HTR2B | P41595 | 1/20 | 0.55 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.53 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27678708 | 0.98 | HRH3 (1.00) | HRH3SIGMAR1MPOKDM4EHTR2A | |
| SCHEMBL19043541 | 0.87 | HRH3 (0.80) | HRH3SIGMAR1MPOKDM4EHTR2A | |
| SCHEMBL10454920 | 0.82 | HRH3 (0.72) | HRH3SIGMAR1MPOKDM4EKCNH2 | |
| SCHEMBL7946364 | 0.81 | MPO (0.81) | HRH3MPOKDM4EALDH1A1GAA | |
| SCHEMBL10415354 | 0.79 | MPO (0.84) | HRH3MPOKDM4EALDH1A1GAA | |
| SCHEMBL5139433 | 0.78 | HRH3 (0.61) | HRH3SIGMAR1MPOKDM4EALDH1A1 | |
| SCHEMBL28001277 | 0.78 | KCNH2 (0.79) | HRH3SIGMAR1KDM4ESLC6A3KCNH2 | |
| SCHEMBL11267644 | 0.78 | HRH3 (0.61) | HRH3SIGMAR1HTR2AHTR2CSLC6A3 | |
| SCHEMBL8673775 | 0.78 | SIGMAR1 (0.65) | HRH3SIGMAR1HTR2ASLC6A3KCNH2 | |
| SCHEMBL791561 | 0.78 | HRH3 (0.61) | HRH3SIGMAR1SLC6A3KCNH2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1361851-A4 | PRIMARY INTERMEDIATES FOR OXIDATIVE COLORATION OF HAIR | P & G CLAIROL INC (US) | 2004-12-15 | — | — | EP | disclosed |
| EP-1361851-A1 | PRIMARY INTERMEDIATES FOR OXIDATIVE COLORATION OF HAIR | P & G-Clairol, Inc. (US) | 2003-11-19 | — | — | EP | disclosed |
| US-6534525-B1 | Method of using 2- substituted piperidine analogs as selectively active antagonist of N-methyl-D-aspartate (NMDA) receptor subtypes for treating conditions such as stroke, cerebral ischemia, central nervous system trauma, | WARNER-LAMBERT & COMPANY | 2003-03-18 | — | — | US | disclosed |
| WO-2002058653-A1 | PRIMARY INTERMEDIATES FOR OXIDATIVE COLORATION OF HAIR | P&G CLAIROL, INC. (US) | 2002-08-01 | — | — | WO | disclosed |
| US-6124317-A | ACTIVE DRUG TREATING STROKE, CEREBRAL ISCHEMIA, CENTRAL NERVOUS SYSTEM TRAUMA, HYPOGLYCEMIA, ANXIETY, CONVULSIONS, AMIOGLYCOSIDE ANTIBIOTICS-INDUCED HEARING LOSS, MIGRAINE HEADACHES, CHRONIC PAIN, GLAUCOMA, CMV RETINITIS, PSYCHOSIS | WARNER-LAMBERT COMPANY (US) | 2000-09-26 | — | — | US | disclosed |
| WO-1997023215-A1 | 2-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE-SELECTIVE NMDA RECEPTOR ANTAGONISTS | WARNER-LAMBERT COMPANY (US) | 1997-07-03 | — | — | WO | disclosed |